The ERS International Congress is one of the biggest annual events in the respiratory calendar—bringing over 20,000 respiratory professionals together for the latest scientific knowledge and hot topics in respiratory medicine.
Our Congress is an inclusive event; the programme has something for everyone, whether you are a clinician, a scientist or allied health professional, whether you are in the early stages of your career or a professional with many years’ experience.
The improvement in awareness, the recent radiological techniques advancement, and the accumulating experience on diagnosis of small, peripheral pulmonary nodules (especially through the lung cancer screening programs, which was dramatically increased worldwide), along with the tremendous diffusion of immunohistochemistry in the pathological diagnosis of lung neoplasms, made a sensible growing of thoracic neuroendocrine tumor (TNT) diagnosis possible, in the last decades. The interest to TNTs management has never been so strong as in the last few years. Several articles concerning biology, associated paraneoplastic syndromes, surgery, imaging, follow-up schedule, new drugs available both in induction and/or in adjuvant setting, have been recently published.
This special issue of the Journal of Thoracic Disease (JTD) represents 35 distinguished oral presentations that have been accepted in the field of Thoracic Surgery dedicated to the 16th annual meeting and conference of Taiwan Association of Thoracic & Cardiovascular Surgery.
As an integral part of precision medicine, the role of liquid biopsy in non-small cell lung cancer (NSCLC) is highlighted in this special issue of Journal of Thoracic Disease with a selection of articles written by a panel of eminent experts. There are many reasons to consider NSCLC as a potential ideal field of application for liquid biopsy: first, the availability of a non-invasive and repeatable method for diagnosis and disease monitoring could be extremely useful in NSCLC patients, considering that physicians have difficulty in obtaining an adequate tumor tissue with standard procedures and that patients are not always suitable to receive a re-biopsy; second, analysis of circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) which originate from all potential lesions could overcome the disadvantages of single site biopsy; last but not least, recent stuxdies showed either that CTCs count may have a prognostic value in NSCLC or that molecular characterization of CTCs/ctDNA may permit the assessment of druggable alterations.
Pulmonary metastasectomy is one of the most common procedures undertaken by thoracic surgery departments worldwide. It is performed to treat lung metastases from primary malignancies with the goal of radically resecting all lung metastases disclosed by preoperative staging CT scan and by intraoperative manual palpation.
Cancer medicine has evolved in recent years thanks to advances in cancer biology, allowing many dedicated scientists and medical oncologists to thoroughly investigate the inner core of cancer cells. The initiative of JTD to gather some of the most prominent Chinese researchers in the field of lung cancer is certainly inspiring for members of the scientific community, especially those dedicated to lung cancer. The selection of Chinese scholars is not arbitrary since all epitomize the main virtues of researchers: full motivation, curiosity, determination and ceaseless work. The readers will find a cornucopia of information on the successes of different Chinese careers and an immense fountain of information and inspiration. Certainly, such salient investigators’ interviews provide a spearhead for further investigators in the complex field of cancer.
We are pleased to announce this focused issue of the Journal of Thoracic Disease on “interventional pulmonology”. Thoracic procedures are better tolerated when they are minimally invasive, leading to shorter hospital stays, fewer complications, and possibly lower costs.
This focused issue provides the reader with a “state-of-art” vision of the BRS technology (and the related clinical results) as it stands in 2017. It begins with an original overview of Italian Interventional Cardiologists regarding past, present and future of BRS technology. Then, it develops important topics such as BRS clinical performance in different settings (i.e., acute coronary syndromes, small vessels, diabetic patients), the role of intracoronary imaging in guiding BRS implantation, the mechanical behavior of polymeric and metallic BRS. In addition, the limitations of current BRS and their possible solution are summarized. Finally, the issue opens to the future with an update on new BRS platforms and their early clinical results.
This issue covers subjects about surgical anatomy, the proper anaesthesia during the intervention, diagnostic aspects, the selection of patients for neoadjuvant therapy, the best neoadjuvant therapy, the extension of mediastinal lymphadenectomy, the proper surgical treatment for squamous cell cancer and adenocarcinomas, as well as esophagogastric junctional tumors, the issue of the adequate checklist and fast track modalities, and the issue when to start with feeding of patients after operation.
Over the last decade, there has been a fervent interest in less invasive approaches to valvular and structural interventions. In the current supplement issue of the Journal of Thoracic Disease, contributing authors present original research and meta-analytic studies, review articles, and editorials regarding these innovative techniques in the field of valvular and structural heart disease.
In this issue, we report, talk and discuss on the need to unify criteria for image techniques, the last guidelines on aortic diseases, the need of new predictive models for mortality after aortic surgery, surgical and image techniques challenges, reoperations, the role of medical treatment on these diseases, we show sparing aortic root repairs. We even talk about the problem of health care cost control in Spain and other European countries where there is public and free Health System or the birth of the Star Chamber, an ingenious idea to prevent surgeons from running away from high-risk interventions
The aim of the International Workshop “EBUS-TBNA for Lung Cancer Diagnosis and Staging—State of the Art”, held in Varese in October 2016, was to present and compare results from national and international experts on this topic. Different issues have been analysed and discussed, including the points of view of pathologist, oncologist, chest physician, and surgeon. Finally, the EBUS-TBNA perspective has been explored through an active and useful discussion among the panellists. These topics have been summarised in this supplement of the Journal of Thoracic Disease with the aim to provide a recent update.